glp-1 small molecule agonist Oral Small-Molecule Receptor Agonists: Mechanistic Insights and Emerging Therapeutic Strategies In the ATTAIN-1 phase 3,

Neuroprotectin D1 (n.d.): a DHA-derived mediator that protects brain and retina against cell injury-induced oxidative stress

Interacting with the insulin receptor, which helps promote cell growth and regulate blood glucose levels throughout the body (thereby improving glucose uptake and metabolic function) Increasing the number and size of myofibrils while improving sarcomere organization, leading to a boost in skeletal muscle fiber growth

30 60

The connection between caloric restriction, increased fat mobilization demand, and the need for efficient mitochondrial fatty acid transport is well-established in biochemistry

Promote collagen and skin barrier function for improved resilience